Lipopolysaccharide suppresses IgE‐mast cell‐mediated reactions
Authors:
- 21 August 2017
- journal article
- research article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 47 (12) , 1574-1585
Abstract
Summary: Background: Clinical and experimental analyses have identified a central role for IgE/FcεRI/mast cells in promoting IgE‐mediated anaphylaxis. Recent data from human studies suggest that bacterial infections can alter susceptibility to anaphylaxis.Objective: We examined the effect of LPS exposure on the induction of IgE‐mast cell (MC) mediated reactions in mice.Methods: C57BL/6 WT, tlr4−/− and IL10−/− mice were exposed to LPS, and serum cytokines (TNF and IL‐10) were measured. Mice were subsequently treated with anti‐IgE, and the symptoms of passive IgE‐mediated anaphylaxis, MC activation, Ca2+‐mobilization and the expression of FcεRI on peritoneal MCs were quantitated.Results: We show that LPS exposure of C57BL/6 WT mice constraints IgE‐MC–mediated reactions. LPS‐induced suppression of IgE‐MC–mediated responses was TLR‐4‐dependent and associated with increased systemic IL‐10 levels, decreased surface expression of FcεRI on MCs and loss of sensitivity to IgE activation. Notably, LPS‐induced desensitization of MCs was short term with MC sensitivity to IgE reconstituted within 48 hours, which was associated with recapitulation of FcεRI expression on the MCs. Mechanistic analyses revealed a requirement for IL‐10 in LPS‐mediated decrease in MC FcεRI surface expression.Conclusions & Clinical Relevance: Collectively, these studies suggest that LPS‐induced IL‐10 promotes the down‐regulation of MC surface FcεRI expression and leads to desensitization of mice to IgE‐mediated reactions. These studies indicate that targeting of the LPS‐TLR‐4‐IL‐10 pathway may be used as a therapeutic approach to prevent adverse IgE‐mediated reactions.Keywords
Funding Information
- National Institutes of Health (R01 AI073553, R01 DK090119, P30DK078392, U19A1070235)
This publication has 86 references indexed in Scilit:
- Intestinal Mast Cell Levels Control Severity of Oral Antigen-Induced Anaphylaxis in MiceThe American Journal of Pathology, 2012
- Rapid oral desensitization in combination with omalizumab therapy in patients with cow’s milk allergyJournal of Allergy and Clinical Immunology, 2011
- Mast cell-orchestrated immunity to pathogensNature Reviews Immunology, 2010
- Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanismProceedings of the National Academy of Sciences, 2009
- NF- B as a Critical Link Between Inflammation and CancerCold Spring Harbor Perspectives in Biology, 2009
- The modulatory effects of lipopolysaccharide‐stimulated B cells on differential T‐cell polarizationImmunology, 2008
- IL-9– and mast cell–mediated intestinal permeability predisposes to oral antigen hypersensitivityJournal of Experimental Medicine, 2008
- Anaphylaxis: Lessons from mouse modelsJournal of Allergy and Clinical Immunology, 2007
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Toll-like receptors and innate immunityNature Reviews Immunology, 2001